Dr. Sandeep Grover, MD

Dr. Grover practices at UF Health Jacksonville in Jacksonville, Florida, part of UF Health.

Dr. Grover's NPI, 1437121324, was assigned on February 3, 2006. Dr. Grover graduated from Pt. B.D. Sharma Postgrad Institute of Medical Science in 1985. Dr. Grover holds Florida license ME93906.

Dr. Grover's primary practice is UF Health Jacksonville, at 655 W 8th St, Jacksonville, FL 32209 in Duval County. The practice phone is (904) 244-4000.

Dr. Grover's primary practice is UF Health Jacksonville in Jacksonville, Florida, part of UF Health. The medical group on file is UF Jacksonville Physicians, Inc. Dmand AI also links Dr. Grover to 1 more skilled nursing facility, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grover practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Grover's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Grover's licenses on file in 3 states: Florida, Illinois and Ohio.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, glaucoma, hereditary corneal conditions and hypertensive retinopathy among the conditions Dr. Grover treats.

CMS data shows 682 Medicare services from Dr. Grover across 5 procedure codes in 2024, for 221 Medicare patients. Medicare paid $38,368 for them.

CMS counts 221 Medicare patients who saw Dr. Grover in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grover's median patient age at 70, with 62% women.

In 2024, Dr. Grover wrote 213 Medicare Part D claims for 70 patients. 69% of them were for generic drugs. CMS names the drug for 191 of them, across 5 drugs with 11 or more claims each, at $2,921 in total drug cost. In 2023, CMS named 282 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 60 out of 100 for Dr. Grover for performance year 2024, reported through an alternative payment model (APM). Dr. Grover accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 876 papers to Dr. Grover, published from 2006 to 2025. 2020 was the busiest year, with 90. The most frequent topics are India, Schizophrenia and Antipsychotic Agents. Dr. Grover has published most often in Indian J Psychiatry. Dr. Grover's most frequent co-authors are Kakarla V. Chalam, MD, Akhilesh Kumar Sharma, MD and Ashish Bhalla, MD.

Dmand AI links Dr. Grover to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Retinitis Pigmentosa, Retinal Dystrophies and Diabetic Retinopathy. Jaeb Center for Health Research sponsors the most, 2.

CMS Open Payments shows 76 general payments to Dr. Grover from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 87% of the total. Janssen Pharmaceuticals, Inc paid the most, $55,432.

Dmand AI lists 10 awards for Dr. Grover, most recently MOMS for Sight Visionary Award in 2015.

Dr. Grover graduated from Pt. B.D. Sharma Postgrad Institute of Medical Science in 1985. Dr. Grover is a member of AAO.

Dr. Grover is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.